Effects of Growth Hormone Treatment in Adults with Prader-Willi Syndrome
dc.contributor.author | Butler, Merlin G. | |
dc.contributor.author | Smith, Bryan K. | |
dc.contributor.author | Lee, Jaehoon | |
dc.contributor.author | Gibson, Cheryl A. | |
dc.contributor.author | Schmoll, C. | |
dc.contributor.author | Moore, W. V. | |
dc.contributor.author | Donnelly, Joseph E. | |
dc.date.accessioned | 2017-06-13T15:24:01Z | |
dc.date.available | 2017-06-13T15:24:01Z | |
dc.date.issued | 2013-06 | |
dc.identifier.citation | Butler, M. G., Smith, B. K., Lee, J., Gibson, C., Schmoll, C., Moore, W. V., & Donnelly, J. E. (2013). Effects of Growth Hormone Treatment in Adults with Prader-Willi Syndrome. Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society, 23(3), 81–87. http://doi.org/10.1016/j.ghir.2013.01.001 | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/24479 | |
dc.description.abstract | OBJECTIVE: Since limited data exist on adults with Prader-Willi syndrome (PWS) and growth hormone (GH) treatment, we report our experience on the effects of treatment for one year on body composition, physical activity, strength and energy expenditure, diet, general chemistry and endocrine data with quality of life measures. DESIGN: We studied 11 adults with PWS (6F:5M; average age = 32 yrs) over a 2 year period with GH treatment during the first year only. Electrolytes, IGF-I, glucose, thyroid, insulin, lipids, body composition, physical activity and strength, diet, energy expenditure and quality of life data were collected and analyzed statistically using linear modeling at baseline, at 12 months following GH therapy and at 24 months after treatment cessation for 12 months. RESULTS: Total lean muscle mass was significantly increased (p < 0.05) during GH treatment along with moderate-vigorous physical activity and plasma IGF-I and HDL levels, but returned to near baseline after treatment. Percent body fat decreased during the 12 months of GH treatment but increased after treatment. CONCLUSIONS: Previously reported beneficial effects of GH treatment in children with PWS were found in our adults regarding body composition, physical activity and plasma HDL and IGF-I levels. Several beneficial effects diminished to near baseline after cessation of GH treatment for 12 months supporting the continuation of treatment in PWS into adulthood and possibly adults not previously treated during childhood. | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 4.0 (CC BY-NC-ND 4.0), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en_US |
dc.subject | Growth hormone treatment | en_US |
dc.subject | Prader-Will syndrome adults | en_US |
dc.subject | Body composition | en_US |
dc.subject | Energy expenditure | en_US |
dc.subject | Physical activity | en_US |
dc.title | Effects of Growth Hormone Treatment in Adults with Prader-Willi Syndrome | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Lee, Jaehoon | |
kusw.kuauthor | Donnelly, Joseph E. | |
kusw.kudepartment | Life Span Institute | en_US |
dc.identifier.doi | 10.1016/j.ghir.2013.01.001 | en_US |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.identifier.pmid | PMC4144013 | en_US |
dc.rights.accessrights | openAccess |
Files in this item
This item appears in the following Collection(s)
-
Life Span Institute Scholarly Works [127]
This collection contains work by the faculty and researchers affiliated with the Life Span Institute.
Except where otherwise noted, this item's license is described as: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 4.0 (CC BY-NC-ND 4.0), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.